JTE-907
JTE-907 is a highly selective, orally active CB2 receptor inverse agonist and exerts anti-inflammatory effects in vivo[1].
Product Specifications
CAS Number
[282089-49-0]
UNSPSC
12352005
Hazard Statement
H302
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jte-907.html
Purity
98.72
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1=CC2=C(NC1=O)C(OCCCCC)=C(OC)C=C2)NCC3=CC=C(OCO4)C4=C3
Molecular Formula
C24H26N2O6
Molecular Weight
438.47
Precautions
H302
References & Citations
[1]Ueda Y, et al. Involvement of cannabinoid CB (2) receptor-mediated response and efficacy of cannabinoid CB (2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Eur J Pharmacol. 2005 Sep 27;520 (1-3) :164-71.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1092088-01 0.02 mg (E-Coli)
Recombinant Microcystis aeruginosa UDP-3-O-acylglucosamine N-acyltransferase (lpxD)
Ask
View Details 
MBS1092088-02 0.02 mg (Yeast)
Recombinant Microcystis aeruginosa UDP-3-O-acylglucosamine N-acyltransferase (lpxD)
Ask
View Details MBS1092088-03 0.1 mg (E-Coli)
Recombinant Microcystis aeruginosa UDP-3-O-acylglucosamine N-acyltransferase (lpxD)
Ask
View Details 
MBS1092088-04 0.1 mg (Yeast)
Recombinant Microcystis aeruginosa UDP-3-O-acylglucosamine N-acyltransferase (lpxD)
Ask
View Details MBS1092088-05 0.02 mg (Baculovirus)
Recombinant Microcystis aeruginosa UDP-3-O-acylglucosamine N-acyltransferase (lpxD)
Ask
View Details MBS1092088-06 0.02 mg (Mammalian-Cell)
Recombinant Microcystis aeruginosa UDP-3-O-acylglucosamine N-acyltransferase (lpxD)
Ask
View Details